Quality of Life After Heart Transplantation: Instruments, Domains, and Variations by Time, Age, and Gender

Area of Science:

• Cardiology
• Transplantation Medicine
• Health Outcomes Research

Background:

• Quality of life (QoL) is increasingly vital in heart transplantation, complementing graft survival and clinical morbidity metrics.
• Advances in surgical techniques and immunosuppression have improved long-term survival, making patient functioning and daily life experiences clinically relevant.
• Understanding QoL evolution is essential for comprehensive patient care post-heart transplant.

Purpose of the Study:

• To synthesize current evidence on Quality of Life (QoL) in heart transplant recipients.
• To analyze QoL across physical, psychological, social, and treatment-related domains over early, intermediate, and long-term follow-up.
• To identify key determinants influencing QoL and patient experience throughout the post-transplant journey.

Main Methods:

• Literature review synthesizing contemporary evidence on QoL in heart transplantation.
• Summary of established QoL assessment tools used in heart transplant recipients.
• Analysis of factors influencing QoL, including exercise capacity, emotional recovery, social reintegration, and immunosuppressive burden.

Main Results:

• QoL in heart transplant recipients encompasses physical, psychological, and social dimensions that change over time.
• Key determinants of QoL include exercise capacity, emotional well-being, social support, and the impact of immunosuppressive therapy.
• Long-term survivors demonstrate sustained QoL benefits alongside emerging challenges, highlighting the need for ongoing management.

Conclusions:

• Quality of life is a critical outcome in heart transplantation, evolving across different post-transplant phases.
• A multidimensional approach is necessary to assess and manage QoL, considering physical, psychological, social, and treatment-related factors.
• This review provides a comprehensive overview for clinicians and researchers on evaluating QoL in heart transplant patients, particularly long-term survivors.